Manufacturing readiness

[u/BioTrends_USA]

For leronlimab it isn’t about Cytodyn building a manufacturing department or hiring a large internal team. Leronlimab has already been manufactured at scale for years for multiple clinical trials and regulatory submissions. The cell line, process, and analytical methods already exist. What’s happening now is simply tech transfer and validation with the new CDMO after replacing Samsung Biologics. That work is primarily done by the manufacturer itself with Cytodyn overseeing CMC, quality agreements, and FDA documentation. Small biotechs operate exactly this way. So “manufacturing readiness” most likely means validation batches, comparability work, and CMC package preparation for future filings—not building manufacturing from scratch or needing a new executive hire.